Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

Thursday, 5 January 2017
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an additional 750,000 shares. The offering, including the sale of the additional shares, is expected to close on January 9, 2017, subject to customary closing conditions. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including comme

Recent related news

Advertisement
MALVERN, Pa.--(BUSINESS WIRE)--PQ Group Holdings Inc. (“PQ” or the “Company”) today announced the launch of its initial public offering of 29,000,000...
6 days ago • Business Wire
NEW YORK--(BUSINESS WIRE)--Deutsche High Income Opportunities Fund, Inc. (NYSE:DHG) (the “Fund”) announced today that the Fund’s Board of Directors has...
4 days ago • Business Wire
MINNEAPOLIS--(BUSINESS WIRE)--Celcuity Inc. (“Celcuity”) (NASDAQ: CELC), a functional cellular analysis company that is discovering new cancer subtypes and...
3 days ago • Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta...
4 days ago • Business Wire
MINNEAPOLIS--(BUSINESS WIRE)--Celcuity Inc. (NASDAQ: CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing...
5 days ago • Business Wire
HERNDON, Va.--(BUSINESS WIRE)--Beacon Roofing Supply, Inc. (NASDAQ: BECN) (“Beacon”) announced today that it is offering to sell, subject to market and other...
1 week ago • Business Wire

You might like